ALB and cancer: The aim of this systematic review and meta-analysis was to investigate the prognostic value of FAR in malignancies based on the available evidence.<h4>Method</h4>To systematically search the Cochrane Library, Embase, PubMed, Google Scholar, Baidu scholars, CNKI and VIP databases for relevant studies published before April 1, 2022, and to evaluate the fibrinogen-to-albumin ratio (FAR) and survival of patients with malignant tumors through a meta-analysis relationship between the results.